JungWoo Shin | Microbial Pathogenesis | Best Researcher Award

Published on by Infectious

Mr. JungWoo Shin | Microbial Pathogenesis | Best Researcher Award

Master’s degree | KyungHee University | South Korea

Prof. Jung-Woo Shin is an accomplished researcher in the field of biomedical and pharmaceutical sciences, currently completing his M.S. at the College of Pharmacy, KyungHee University , following a B.S. in Biomedical & Medical and Pharmaceutical Materials with a double major from Hallym University . His professional experience encompasses extensive work on the modulation of gut microbiota and the therapeutic potential of probiotics, including Lactococcus lactis, Bifidobacterium longum, and Lactobacillus plantarum, in alleviating gastrointestinal disorders, neuroinflammation, liver injury, fibrosis, and anxiety- and depression-like behaviors in preclinical mouse models. Prof. Shin’s research interests focus on the intersection of microbiology, immunology, neuropharmacology, and translational therapeutics, particularly in understanding the mechanisms by which gut microbiota and probiotic interventions influence systemic and neurological health via pathways such as NF-κB, AMPK signaling, and IL-6 regulation. His research skills include in vivo modeling, molecular biology techniques, microbiome analysis, histopathology, and behavioral assays, as reflected in his publications in high-impact journals such as Letters in Applied Microbiology, Journal of Microbiology and Biotechnology, and Microbes and Infection. Prof. Shin has been recognized for his contributions to the field through various academic awards and honors during his graduate and undergraduate studies. He continues to advance innovative probiotic-based therapeutic strategies with translational potential for human health, aiming to bridge basic research and clinical application. His work has garnered significant recognition, with 2,427 citations , 94 published works, and an h-index of 26, underscoring his impactful contribution to biomedical research and the scientific community.

Profiles : Google Scholar | Scopus | ORCID

  1. Park, S. Y., Park, C., Seo, J., & Shin, J. (2025). Public willingness to pay for chemical regulation in South Korea: The case of restriction on arsenic use. Environment, Development and Sustainability, 27(5), 11509–11526.
    Citations: 2
  2. Oh, M., Moon, H. B., Woo, J. R., Kim, H., & Shin, J. (2024). How to be a winner of future vehicle maintenance services: Consumer preference for vehicle self-diagnosis and fault prediction system in next-generation vehicles. Technology Analysis & Strategic Management, 1–13.
    Citations: 2
  3. Hong, Y., Shin, J., Choi, H., & Ahn, J. W. (2024). Investigating the value of parallel pipeline projects for water supply: A contingent valuation study in South Korea. Water, 16(6), 819.
    Citations: 2
  4. Kim, K., Shin, J., & Choi, J. Y. (2017). Impact analysis of economic contributors on knowledge creation activity by using the symmetric decomposition method. Symmetry, 9(11), 251.
    Citations: 2
  5. Kang, C., Lee, C., Zhao, X., Lee, D., Shin, J., & Lee, J. (2025). Safety still matters: Unveiling the value propositions of augmented reality head-up displays in autonomous vehicles through conjoint analysis. Travel Behaviour and Society, 39, 100915.
    Citations: 1

Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

Published on by Infectious

Dr. Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

MD | Tehran University of Medical Sciences | Iran

Dr. Shayan Zamani is a dedicated Clinical Research Fellow at the Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, where he has established a strong foundation in dermatology, oncology, and hematopoietic stem cell transplantation. He earned his Doctor of Medicine (MD) with a focus on dermatologic research and clinical therapeutics, combining his medical expertise with evidence-based research in complex dermatological and oncologic disorders. Throughout his career, Dr. Zamani has contributed to multidisciplinary research collaborations exploring topics such as graft-versus-host disease (GVHD), drug-resistant fungal infections, cutaneous complications in oncology patients, and innovative nanoliposomal treatments for fungal and inflammatory skin diseases. His professional experience spans both clinical and laboratory environments, where he integrates translational methodologies to improve diagnostic precision and patient outcomes. His research interests center on dermatologic oncology, infectious skin diseases, immunodermatology, and regenerative therapies, supported by his skills in clinical trial design, biomarker analysis, molecular diagnostics, and data-driven evaluation of treatment efficacy. Dr. Zamani has authored several peer-reviewed publications in reputable journals such as JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Frontiers in Oncology, and Dermatologic Therapy, contributing valuable insights into skin disease pathophysiology and treatment optimization. His work has earned him recognition for academic excellence and commitment to advancing medical science. Dr. Zamani has actively participated in research collaborations and conferences, reflecting strong leadership and dedication to clinical innovation. With a growing publication record and a clear focus on improving therapeutic outcomes, he continues to strengthen his role in advancing dermatologic and oncologic research globally. His academic impact is demonstrated by 19 citations , 11 publications, and an h-index of 3.

Profiles : Google Scholar | Scopus | ORCID

Featured Publications

1. Tamimi, P., Fattahi, M., Ghaderi, A., Firooz, A., Shirvani, F., Alkhen, A., & Zamani, S. (2024). Terbinafin‐resistente Trichophyton indotineae mit F397L/L393S‐ oder F397L/L393F‐Mutation bei Patienten mit Tinea incognita unter Glukokortikosteroiden. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(7), 922–935.

2. Samadi, A., Ayatollahi, A., Kashani, M. N., Zamani, S., & Firooz, A. (2023). Efficacy and tolerability assessment of a polynucleotide‐based gel for improvement of pattern hair loss: A polynucleotide‐based gel for improvement of pattern hair loss. [Journal name not specified].

3. Mehdizadeh, M., Tehrani, H. A., Rezvani, H., Zamani, S., Salari, S., & Hajifathali, A. (2023). Maintenance therapy with Everolimus in patients with refractory or relapsing Hodgkin lymphoma after autologous stem cell transplantation. Blood Cell Therapy, 6(3), 87–93.

4. Zamani, S., Azhdari, H., & Mehdizadeh, M. (2023). Efficacy and safety profile of Everolimus as a maintenance therapy for primary refractory/relapsing Hodgkin lymphoma following autologous hematopoietic stem cell transplantation. HemaSphere, 7(S3), e9236902.

5. Zamani, S., Mehdizadeh, M., & Salem, A. (2023). Allogeneic stem cell transplantation outcomes in Hodgkin lymphoma: A prognostic study of 30 patients with relapsed and refractory Hodgkin lymphoma. HemaSphere, 7(S3), e621289b.

 

Hassan Babamohamadi | Viral Infections | Best Researcher Award

Published on by Infectious

Prof. Dr. Hassan Babamohamadi | Viral Infections | Best Researcher Award

Clinical Trial | Semnan University of Medical Sciences | Iran

Dr. Hassan Babamohamadi is a distinguished Professor of Nursing at Semnan University of Medical Sciences, Iran, recognized for his extensive contributions to nursing education, clinical practice, and research. His scholarly work encompasses diverse areas, including medical education, critical thinking, spinal cord injury, hemodialysis care, pain management, chronic disease adjustment, psychometrics, and complementary medicine. He has played a key role in advancing the quality of nursing curricula through numerous comparative studies evaluating Iranian nursing programs against international standards, contributing significantly to the development of evidence-based educational frameworks. His clinical research has explored innovative interventions such as spiritual care models, acupressure, aromatherapy, rhythmic breathing, and family-based participatory programs, offering valuable insights into patient recovery, mental health, and holistic well-being. With a strong focus on both qualitative and quantitative methodologies, Dr. Babamohamadi’s studies emphasize improving patient outcomes, enhancing healthcare professionals’ competencies, and integrating ethical and spiritual dimensions into modern nursing. His publications in prestigious journals like BMC Nursing, Journal of Religion and Health, Complementary Therapies in Medicine, and Australian Critical Care highlight his commitment to interdisciplinary research and global academic collaboration. In addition to his prolific research output, he has contributed as an editorial board member and peer reviewer for several reputable journals, supporting the advancement of nursing science and evidence-based clinical practice. His leadership roles within academic administration, including serving as head of the Medical-Surgical Nursing Department and vice chancellor of education, reflect his dedication to academic excellence and institutional development. Dr. Babamohamadi’s research continues to influence the evolution of nursing education and clinical innovation, strengthening the bridge between theory and practice across health sciences. 3806 Citations, 56 Documents, 17 h-index, View h-index.

Profiles : Google Scholar | Scopus| ORCID

Featured Publications

Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., … (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402(10397), 203–234.Cited by 3415

Shin, Y. H., Hwang, J., Kwon, R., Lee, S. W., Kim, M. S., … (2023). Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study. Allergy, 78(8), 2232–2254.Cited by 298

Safdarian, M., Trinka, E., Rahimi-Movaghar, V., Thomschewski, A., Aali, A., … (2023). Global, regional, and national burden of spinal cord injury, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 22(11), 1026–1047.Cited by 216

Pourteimour, S., Yaghmaei, S., & Babamohamadi, H. (2021). The relationship between mental workload and job performance among Iranian nurses providing care to COVID‐19 patients: A cross-sectional study. Journal of Nursing Management, 29(6), 1723–1732.Cited by 206

Bender, R. G., Sirota, S. B., Swetschinski, L. R., Dominguez, R. M. V., Novotney, A., … (2024). Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: A systematic analysis from the Global Burden of Disease Study. The Lancet Infectious Diseases, 24(9), 974–1002.Cited by 203

Prof. Ying Liao | Animal virus | Best Researcher Award

Published on by Infectious

Prof. Ying Liao | Animal virus | Best Researcher Award

Shanghai Veterinary Research Institute, Chinese Academy of Agricultutral Science | China.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Prof. Ying Liao began her academic journey with a B.Sc. from East China Normal University (1993–1997), laying the groundwork for her passion in molecular virology and infectious diseases. She further honed her expertise through a Ph.D. in Biological Sciences at Nanyang Technological University, Singapore (2002–2007), where she embarked on groundbreaking research into coronavirus biology and viral-host interactions, setting the tone for a stellar scientific career.

💼PROFESSIONAL ENDEAVORS

Prof. Liao’s professional path reflects her unwavering commitment to virology research and leadership. She held research fellow positions at both Nanyang Technological University and the Institute of Molecular and Cell Biology, A*STAR Singapore, between 2007–2014. In 2014, she joined the Shanghai Veterinary Research Institute (SHVRI) of the Chinese Academy of Agricultural Sciences (CAAS) as a Professor, where she currently serves as Group Leader and Principal Investigator of the Avian Viral Diseases Team. Her team is central to China’s national strategy on animal infectious disease control and vaccine innovation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANIMAL VIRUS

Prof. Ying Liao’s research centers on animal virus pathogenesis, especially coronaviruses, flaviviruses, and paramyxoviruses. Her work has made significant contributions in:

  • Understanding virus-host molecular mechanisms

  • Dissecting immune evasion pathways

  • Developing diagnostic tools and antiviral therapeutics

  • Exploring translational control during infection

Her team uses coronavirus and paramyxovirus models to study innate immunity suppression, stress granule manipulation, and translation shutoff, delivering insights that are not only academically profound but also clinically and agriculturally impactful.

🌍IMPACT AND INFLUENCE

Prof. Liao’s discoveries have broad implications in the fields of veterinary virology, pandemic preparedness, and vaccine design. Her research has informed global scientific understanding of zoonotic diseases and has contributed directly to the development of protective vaccines and antiviral strategies against infectious bronchitis virus (IBV) and Newcastle Disease Virus (NDV). As an internationally respected virologist, she continues to collaborate with leading figures across Asia, Europe, and the Americas, enhancing One Health frameworks worldwide.

🏆RESEARCH GRANTS AND FUNDING

Prof. Ying Liao has successfully led and secured over 12 major research grants, including:

  • 🇨🇳 National Natural Science Foundation of China (NSFC)

  • 🧬 National Key R&D Program of China

  • 🧪 Shanghai Natural Science Foundation

  • 🏛 Chinese Academy of Agricultural Sciences (CAAS) Elite Youth Program

  • 🔬 Public-Interest Scientific Institution Basal Research Fund

Collectively, these projects total millions in funding, empowering extensive research into coronavirus immune evasion, host translation shutoff, stress granules, and avian vaccine development.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Prof. Liao is shaping the future of infectious disease research in China and beyond. Her legacy includes:

  • The development of a cell line expressing furin protein for avian coronavirus culture (patented)

  • The training and mentorship of numerous postdoctoral researchers and graduate students

  • Significant strides toward universal vaccine strategies for coronaviruses

  • Leadership in the design of molecular diagnostic reagents for rapid outbreak response

Her dedication ensures that her work will outlive current global health challenges and serve as a foundation for next-generation viral therapeutics.

🌟A VISIONARY IN INFECTIOUS DISEASES

A trailblazer in veterinary and molecular virology, Prof. Ying Liao embodies the rare blend of scientific excellence, innovative thinking, and societal relevance. Her relentless pursuit of knowledge in host-pathogen interactions, vaccine innovation, and immune regulation has solidified her role as a visionary leader in infectious diseases. Her strategic foresight and collaborative mindset continue to transform how the scientific community responds to animal and zoonotic viral threats.

📑NOTABLE PUBLICATIONS

🧪Coronavirus endoribonuclease nsp15 suppresses host protein synthesis and evades PKR-eIF2α-mediated translation shutoff to ensure viral protein synthesis

Authors: Gong, Xiaoqian; Feng, Shanhuan; Wang, Jiehuang; Forlenza, Maria; Liao, Ying
Year: 2025
Journal: PLoS Pathogens

🧪Targeting host integrated stress response: lead discovery of flavonoid compounds active against coronaviruses PEDV and PDCoV

Authors: Yi, Liang; Wang, Yishuai; Wang, Jiehuang; Liao, Ying; Zhang, Qingwen
Year: 2024
Journal: RSC Medicinal Chemistry

🧪Newcastle disease virus infection induces parthanatos in tumor cells via calcium waves

Authors: Qu, Yang; Wang, Siyuan; Jiang, Hui; Sun, Yingjie; Ding, Chan
Year: 2024
Journal: PLoS Pathogens

🧪 Coronavirus nucleocapsid protein enhances the binding of p-PKCα to RACK1: Implications for inhibition of nucleocytoplasmic trafficking and suppression of the innate immune response

Authors: Xue, Wenxiang; Chu, Hongyan; Wang, Jiehuang; Ding, Chan; Liao, Ying
Year: 2024
Journal: PLoS Pathogens

🧪FGFR1-mediated enhancement of foot-and-mouth disease virus entry

Authors: Wang, Xuefei; Liao, Ying; Abdullah, Sahibzada Waheed; Sun, Shiqi; Guo, Huichen
Year: 2024
Journal: Veterinary Microbiologyy